Pfizer is almost finished enrolling volunteers in its Phase 3 clinical trial of a Covid 19 vaccine . 
The company has stated it plans to enroll approximately 44,000 participants . 
On Monday , it announced the addition of 270 more volunteers , bringing the current enrollment to 43,931 people . 
More than 42,722 participants have received their second vaccination . 
A final analysis of the Phase 3 trial of Pfizer 's coronavirus vaccine showed it was 95 % effective in preventing infections and caused no serious safety concerns , the company said previously . 
